Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q3 2023 Earnings Call Transcript

Even responding to questions about the GLP-1 impact, I think we’ve got a database just based on our leadership and our girth in number of patients served over the years that allows us to know more about this constituent. So I think Kylee will continue to enrich that. We’re getting a lot more information than we had before about the progression of their measurements as they record those. We can even capture photos. We’re being able to collect information about their usage patterns. And I think to your point, over time, that database becomes really helpful and important as we continue to choose how we deploy new products, what opportunities we have to better serve these patients.

Suraj Kalia: Thank you.

Operator: We are currently seeing no remaining questions at this time. That does conclude our conference for today. Thank you for your participation.

Daniel Reuvers: Thanks, operator.